InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by RUFFOLO ROBERT R, Director. Officer active across 1 company, notably Sigilon Therapeutics, Inc.. Aggregated, 2 filings have been recorded. History available since 1 July 2021. The latest transaction was disclosed on 1 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Robert R. Ruffolo is a Director of Sigilon Therapeutics, Inc. In this role, he contributes to the strategic direction of the company and oversight of its operations. His expertise in the biopharmaceutical sector is essential for guiding Sigilon Therapeutics towards its performance and innovation objectives. He is committed to ensuring good governance and accountability within the board.